(Q48421857)

English

Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus

scientific article published in June 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

subthalamic nucleus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

substantia nigra

1 reference

based on heuristic

inferred from title

author name string

C R Honey

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

H Shen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

language of work or name

0 references

publication date

1 June 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

249

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

2-3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

151-154

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

Striatal D1 dopamine receptor morphochemistry following continuous or intermittent l-DOPA replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pallidotomy: a survey of current practice in North America.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats--an autoradiographic study using [3H]flunitrazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous and intermittent levodopa differentially affect basal ganglia function

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronicl-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900431-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(98)00431-5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9682839

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48421857&oldid=2198425024"